Econ Exam 1 Flashcards

1
Q

Cost-Minimization Analysis (CMA)

A

compares cost of treatments with equivalent outcomes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Cost-Effectiveness Analysis (CEA)

A

measures costs in dollars and outcomes in natural health units —it is the most common type

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Cost-Utility Analysis (CUA)

A

measures costs in dollars and outcomes in quality adjusted life year (QALY)
takes patient preference/satisfactions (utilities) into account
a subset of CEA-outcomes in natural health units

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Cost-Benefit Analysis (CBA)

A

compares both costs and benefits in monetary units $
used in wildlife, irrigation and flood control, air quailty

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Economics

A

The study of how individuals and societies choose to allocate scarce resources, why they choose to allocate them that way, and the consequences of those decisions.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Microeconomics

A

The study of individual decisions
Suppy,demand, elasticity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Macroeconomics

A

The study of the economy as a whole
-inflation, unemployment -the country

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Utility (Satisfaction)

A

Satisfaction obtained from purchasing a particular good or service
if utility of a good is greater than its cost=BUY

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Patient Perspective

A

Pays for the costs not covered by insurance companies
-copayments, deductibles and any out of pocket costs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Provider Perspective

A

Pays for the costs of providing products or services
-drugs, hospitalization and lab test

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Price

A

the charge

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Cost

A

the input

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

ECHO

A

Economic, Clinical, Humanistic, Outcome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Traditional Cost Category

A
  1. Direct Medical Costs
  2. Direct Non-medical costs
  3. Indirect costs
  4. Intangible costs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Direct Medical Costs

A

most obvious cost to measure
directly related to medical treatment
-diagnostic tests, hospitalization, home infusion, medical visits
ambulance to ER service
buying an OTC cold medicine from a local pharmacy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Direct Non-medical Costs

A

Cost to the patient that are directly associated with treatment but are not medical in nature
Examples: cost of traveling to and from clinic, food and lodging for out of town treatment, child care services
-gas fee spent on the way to clinic where you receive steroid injections
-you order food while waiting for son to finish chemo
-buying plane ticket to care for moms recovery
-uber fee spent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Indirect Costs

A

Result from the loss of productivity due to death/illness
Examples: Missing work, or reduced productivity at work due to treatment
-taking a week off from your work to care for ill mom
-come back to work after knee surgery and are slower

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Intangible Costs

A

costs of non-financial outcomes of disease and medial care
examples: nausea from chemotherapy, anxiety during mri scan so take xanax

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Consumer price index (CPI)

A

measure of the average change over time in the prices paid by the consumers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

standardization of costs

A

bringing past costs to the present
CPI as indicator
MULTIPLY (must always add 1 before)
if CPI=4.4%
change to decimal –> 0.044
then add 1 (1+0.044)=1.044
now can multiply the cost by that

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

discounting of costs

A

brining future costs to the present
DIVIDE (must always add 1 before)
if Discount rate= 5%
change to decimal –> 0.05
then add 1 (1+0.05)=1.05
now can divide the cost by that

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Average Wholesale price (AWP)

A

list price/sticker price
higher than what pharmacies actually pay for the meds
-redbook-micromedex

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

wholesale acquisition cost (WAC)

A

catalog price
sale deals and discounts/rebates NOT included

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

average manufacturer price (AMP)

A

amount paid by wholesaler after all sales deals are included
more precise
not available to public

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Common sources for US reimbursement rates

A

physician fee reference
medicare reimbursement rates from CMS (Centers for Medicare and Medicaid Services)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Personnel Costs

A

consideration of the amount of time spent by medical personnel (work time)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Hospitalizations

A
  1. per diem
  2. disease-specific per diem
  3. diagnosis related group
  4. micro-costing
    (more precise as you read down)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

per diem

A

average cost per day for all types of hospitalizations
(key words: per day, all)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

disease-specific per diem

A

estimate the costs based on specific disease state
-appendectomy, cardiac bypass surgery costs, small joint repairs and cataract surgery costs etc.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

diagnosis related group

A

classify diagnosis/procedures that use similar resources
control medicare costs
each category has its own reimbursement rate based on: diagnosis, secondary diagnosis, age, sex, and discharge status
each-patient is categorized

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

micro-casting

A

collects information on resource use for each component of hospitalization
-need to review patients hospital record

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Complete title

A

Good Example
 Cost Benefit Analysis of Ibuprofen vs. Tylenol in Pediatric Patients with Common Cold Symptoms
 Bad Examples
 (Pharmacoeconomic Analysis) of Glipizide vs. Glyburide in the Veterans Administration
 Cost-Effectiveness Analysis of (Two Antibiotic) Therapies in a Large Teaching Hospital
 (Ultraceph Found Cost-Effective) When Compared to Megaceph

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Clear objective

A

stated in the beginning-usually in objective section
-to calculate the benefit to cost ration
NOT-to determine if better

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

appropriate alternatives/comparators

A

new vs current
drug vs nondrug
etc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

alternatives described

A

what resources? services? and description of drug dose and so on

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

perspective stated

A

costs for patients, providers and society

37
Q

type of study

A

knowing upfront what type of study is being done ..CBA, CMA etc. and why it is appropriate for the study

38
Q

relevant costs

A

stated perspective for the costs, time period, and justification
protocol driven costs should be excluded

39
Q

relevant outcomes

A

clinically important and appropriate time periods

40
Q

adjustment or discounting

A

assessing resources over years=use adjusted (standardized)
when costs extrapolated more than 1 year out=use discount rate

41
Q

reasonable assumptions

A

may not be precise or universally agreed upon

42
Q

sensitivity analyses

A

more reliability (robustness) for discount rates
if it supports then your study is more credible

43
Q

limitations addressed

A

no PE study is perfect
limitations: small sample size=disturbs reliability
retrospective data collection=disturbs generalization due to potential bias

44
Q

Appropriate generalizations

A

if used specific population then needs to be specified in the study as a caution against generalizing or extrapolating
-age, gender, socioeconomic status, disease state

45
Q

unbiased conclusion

A

dose study make sense?
does the result show no significant difference but the conclusion strongly supports one of the alternatives

46
Q

when analyzing if a good title

A

answer these:
what is being compared?
what type of study is being conducted?
does the title sound biased?

47
Q

Cost-minimizing analysis (CMA)

A

pharmacoeconomic analysis that compares the costs of treatments assuming that they have equivalent outcomes

48
Q

CMA compares: bioequivalent

A

same active ingredients and same desired outcome

49
Q

CMA compares: 2 different settings at the same doses

A

hospital vs home

50
Q

advantages to CMA

A

simplest -only costs of intervention are compared
easy to convince readers-due to equivalent outcomes

51
Q

Disadvantages to CMA

A

types of interventions are limited
less commonly. used

52
Q

cost analysis

A

if outcomes are not measured it is a partial economic analysis and not a full one

53
Q

cost-effective analysis

A

if outcomes are measured it is an cost effective analysis that has the same effectiveness

54
Q

50th percentile

A

median

55
Q

75th percentile

A

75 percent of the charges for that service are equal to or less than that fee nationwide

56
Q

healthcare professional cost

A

costs per minute
gross annual salaries including fringe benefits

57
Q

drug administration cost

A

hospital supply information

58
Q

drug cost of IV and SC formulations

A

unit cost per treatment cycle
US average wholesale price

59
Q

indirect costs

A

allow for more precise results

60
Q

perspective stated?

A

what costs were measured? patients, providers,payers, society (may not say directly but if see costs then choose it)

61
Q

relevant costs?

A

costs were estimated….medical and billing records…..

62
Q

relevant outcomes?

A

includes time period and same efficacy/scope

63
Q

appropiate generalizations?

A

does not generalize/extrapolates but says appear to be similar but differences can be seen

64
Q

cost-effectiveness analysis (CEA)

A

measures costs in dollars and outcomes in natural health units that indicate an improvement in health
most common type

65
Q

advantages of CEA

A

measured in clinical units-familiar and acceptable to clinicians
outcomes do not need to be converted to monetary values
ex: symptom free days, mmHG, %healed, life years saved, rehospitalizations avoided

66
Q

disadvantages of CEA

A

only one outcome at a time can be compared
so keep to mmHg to mmHG not to FEV
interpretation is subjective -is added benefit worth got the added cost

67
Q

uses of CEA

A

cost of mammogram vs prevention of breast cancer
cost of flu vaccine vs. prevention of influenza

68
Q

average cost (Cost effectiveness ratios) CER

A

total cost/ effectiveness (change % to decimal)

69
Q

marginal costs (incremental cost effective ratios (ICER)

A

change in costs/change in benefits (effectiveness,outcomes…)
(C2-C1) / (E2-E1)

70
Q

for ICER calculation

A

must use CCA (cost and outcomes) not CER

71
Q

high cost and same effectiveness

A

not cost effective

72
Q

same cost and higher effectiveness

A

cost effective

73
Q

lower cost and lower effectiveness

A

other factors may be considered to determine the winner

74
Q

if less effective at a higher cost

A

not considered cost effective

75
Q

if more effective at a lower cost

A

it is considered cost effective

76
Q

if more effective but at a higher cost

A

decision maker must decide if the higher effectiveness is worth the higher cost (trade off 1)

77
Q

if less effective but at a lower cost

A

decision maker must decide if the lower cost is low enough to outweigh the lower effectiveness (trade off 2)

78
Q

cost (+)

Quadrant A. Quadrant B
effect (+)
Quadrant C. Quadrant D

A

quadrant B. is known as Trade off 1-decision maker must decide if the higher effectiveness is worth the higher cost
quadrant D= cost effective
quadrant A= not cost effective
quadrant c= Trade off 2-decision maker must decide if the lower cost is low enough to outweigh the lower effectiveness

79
Q

primary outcomes (final)

A

not feasible due to lack of time and monetary resources
ex: cure of a disease, eradication of an infection, life years saved

80
Q

intermediate outcomes

A

surrogate outcomes _labs, FEV1, mmHG, A1C

81
Q

efficacy

A

does the drug work under controlled conditions?
RCTS are essential
before fda approval

82
Q

effectiveness

A

does the drug work in routine medical practices?
after fda approval

83
Q

efficiency

A

how well does it work?

84
Q

elasticity

A

how much the demand changes as the price changes

85
Q

market equilibrium price

A

the point where the supply and demand curves intersect

86
Q

pharmacoeconomics

A

description and analysis of the costs of drug therapy to health care systems
scientific discipline that evaluates the value of products and services

87
Q

humanistic

A

consequences of disease/treatment perceived and reported by the PATIENT

88
Q

4 types of direct medical costs

A

meds, medical services, personnel costs, hospitalizations